Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 412

2.

Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.

Hoang MP, Amirkhan RH.

Am J Surg Pathol. 2003 Aug;27(8):1152-6.

PMID:
12883249
3.

Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.

Weinbreck N, Marie B, Bressenot A, Montagne K, Joud A, Baumann C, Klein O, Vignaud JM.

Am J Surg Pathol. 2008 Jul;32(7):1051-9. doi: 10.1097/PAS.0b013e3181609d7d.

PMID:
18496143
4.

Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.

Brown DF, Dababo MA, Hladik CL, Eagan KP, White CL 3rd, Rushing EJ.

Mod Pathol. 1998 Jan;11(1):55-9.

PMID:
9556423
5.

Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.

Rivera AL, Takei H, Zhai J, Shen SS, Ro JY, Powell SZ.

Neuropathology. 2010 Dec;30(6):580-5. doi: 10.1111/j.1440-1789.2010.01109.x.

PMID:
20374497
6.

CD10 is expressed in a subset of chromophobe renal cell carcinomas.

Martignoni G, Pea M, Brunelli M, Chilosi M, Zamó A, Bertaso M, Cossu-Rocca P, Eble JN, Mikuz G, Puppa G, Badoual C, Ficarra V, Novella G, Bonetti F.

Mod Pathol. 2004 Dec;17(12):1455-63.

7.

GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.

North PE, Mizeracki A, Mihm MC Jr, Mrak RE.

Clin Neuropathol. 2000 May-Jun;19(3):131-7.

PMID:
14606586
8.

PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.

Carney EM, Banerjee P, Ellis CL, Albadine R, Sharma R, Chaux AM, Burger PC, Netto GJ.

Am J Surg Pathol. 2011 Feb;35(2):262-7. doi: 10.1097/PAS.0b013e3182064d11.

PMID:
21263247
9.
10.
11.
12.

Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease.

Polydorides AD, Rosenblum MK, Edgar MA.

Arch Pathol Lab Med. 2007 Apr;131(4):641-5.

PMID:
17425399
13.

Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.

Ozolek JA, Bastacky SI, Myers EN, Hunt JL.

Laryngoscope. 2005 Jun;115(6):1097-100.

PMID:
15933529
14.

Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease.

Hamazaki S, Nakashima H, Matsumoto K, Taguchi K, Okada S.

Pathol Int. 2001 Dec;51(12):948-53.

PMID:
11844068
15.

Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.

Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.

Am J Surg Pathol. 2007 Oct;31(10):1528-33.

PMID:
17895753
17.

Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma.

Ingold B, Wild PJ, Nocito A, Amin MB, Storz M, Heppner FL, Moch H.

Histopathology. 2008 May;52(6):674-81. doi: 10.1111/j.1365-2559.2008.03003.x. Epub 2008 Apr 2.

PMID:
18393979
18.

Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy.

Simsir A, Chhieng D, Wei XJ, Yee H, Waisman J, Cangiarella J.

Diagn Cytopathol. 2005 Jul;33(1):3-7.

PMID:
15945081
19.

Renal cell carcinoma metastatic to follicular adenoma of the thyroid gland. A case report.

Koo HL, Jang J, Hong SJ, Shong Y, Gong G.

Acta Cytol. 2004 Jan-Feb;48(1):64-8.

PMID:
14969183
20.

Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study.

Pires FR, Azevedo RS, Ficarra G, Cardoso AS, Carlos R, Kowalski LP, de Almeida OP.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Apr;109(4):e22-7. doi: 10.1016/j.tripleo.2009.12.006.

PMID:
20303042
Items per page

Supplemental Content

Write to the Help Desk